Literature DB >> 3969684

Metabolism and excretion of orally administrated arsenic trioxide in the hamster.

H Yamauchi, Y Yamamura.   

Abstract

It was shown that a single dose of arsenic trioxide administered to hamsters was chiefly methylated in vivo into methylarsonic acid (MAA) and dimethylarsinic acid (DMAA), and that inorganic arsenic accounted for the major portion of total arsenic that deposited in organs and tissues, followed by MAA and DMAA in decreasing sequence of significance. The single oral dose of arsenic trioxide was followed by a very small amount of trimethylarsenic compounds (TMA) occurring only in the liver but not in any other organs, tissues, blood or feces. The distribution pattern of arsenic in the blood following the single oral dose of arsenic trioxide was such that inorganic arsenic and MAA occurred chiefly in the blood cells; DMAA, chiefly in the plasma; and the arsenic compounds disappeared rapidly from blood. The single oral dose of arsenic trioxide was further followed by excretion of an amount of arsenic equivalent to about 60% of the administered dose: 49% in the urine and 11% in the feces. In other words, more arsenic tended to be excreted in the urine. DMAA accounted for the major portion of arsenic excreted in the urine and feces, and this finding re-confirmed that DMAA is the major metabolite of arsenic trioxide. Although it is believed that arsenic trioxide is not converted into TMA, the results of the present study suggest that a very small amount of arsenic trioxide is converted into TMA in the liver.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3969684     DOI: 10.1016/0300-483x(85)90161-1

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  10 in total

Review 1.  Assessing the bioavailability and bioaccessibility of metals and metalloids.

Authors:  Jack C Ng; Albert Juhasz; Euan Smith; Ravi Naidu
Journal:  Environ Sci Pollut Res Int       Date:  2013-06-14       Impact factor: 4.223

2.  Metabolism and excretion of orally and intraperitoneally administered methylarsonic acid in the hamster.

Authors:  H Yamauchi; N Yamato; Y Yamamura
Journal:  Bull Environ Contam Toxicol       Date:  1988-02       Impact factor: 2.151

3.  Concentrations and chemical species of arsenic in human urine and hair.

Authors:  N Yamato
Journal:  Bull Environ Contam Toxicol       Date:  1988-05       Impact factor: 2.151

4.  Metabolism and excretion of orally administered arsenobetaine in the hamster.

Authors:  H Yamauchi; T Kaise; Y Yamamura
Journal:  Bull Environ Contam Toxicol       Date:  1986-03       Impact factor: 2.151

5.  Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.

Authors:  Zuzana Drobná; Stephen B Waters; Vicenta Devesa; Anne W Harmon; David J Thomas; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

6.  Effect of DMPS and various adsorbents on the arsenic excretion in guinea-pigs after injection with As2O3.

Authors:  F X Reichl; G Hunder; B Liebl; B Fichtl; W Forth
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

7.  Effect of various antidotes on the biliary and intestinal excretion of arsenic in situ and into the feces in vivo in guinea-pigs after injection of As2O3.

Authors:  F X Reichl; H Kreppel; L Szinicz; H Mückter; B Fichtl; W Forth
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 8.  Cancer risks from arsenic in drinking water.

Authors:  A H Smith; C Hopenhayn-Rich; M N Bates; H M Goeden; I Hertz-Picciotto; H M Duggan; R Wood; M J Kosnett; M T Smith
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

9.  Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan.

Authors:  Yung-Kai Huang; Ya-Li Huang; Yu-Mei Hsueh; Jimmy Tse-Jen Wang; Mo-Hsiung Yang; Chien-Jen Chen
Journal:  Environ Health Perspect       Date:  2009-07-29       Impact factor: 9.031

10.  Erythema multiforme due to arsenic trioxide in a case of acute promyelocytic leukemia: A diagnostic challenge.

Authors:  Girish V Badarkhe; Amrita Sil; Sabari Bhattacharya; Uttam Kumar Nath; Nilay Kanti Das
Journal:  Indian J Pharmacol       Date:  2016 Mar-Apr       Impact factor: 1.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.